April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Noninvasive Assessment of Retinal Vascular Leakage by Dynamic Contrast Enhanced Magnetic Resonance Imaging
Author Affiliations & Notes
  • Y. Qiu
    Novartis, Cambridge, Massachusetts
  • M. S. Hansen
    Novartis, Cambridge, Massachusetts
  • F. SariSarraf
    Novartis, Cambridge, Massachusetts
  • Y. Jiang
    Novartis, Cambridge, Massachusetts
  • E. Eckersdorff
    Novartis, Cambridge, Massachusetts
  • B. Jaffee
    Novartis, Cambridge, Massachusetts
  • J. Tsao
    Novartis, Cambridge, Massachusetts
  • S. Poor
    Novartis, Cambridge, Massachusetts
  • Footnotes
    Commercial Relationships  Y. Qiu, Employee of Novartis, E; M.S. Hansen, Employee of Novartis, E; F. SariSarraf, Employee of Novartis, E; Y. Jiang, Employee of Novartis, E; E. Eckersdorff, Employee of Novartis, E; B. Jaffee, Employee of Novartis, E; J. Tsao, Employee of Novartis, E; S. Poor, Employee of Novartis, E.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 4928. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Qiu, M. S. Hansen, F. SariSarraf, Y. Jiang, E. Eckersdorff, B. Jaffee, J. Tsao, S. Poor; Noninvasive Assessment of Retinal Vascular Leakage by Dynamic Contrast Enhanced Magnetic Resonance Imaging. Invest. Ophthalmol. Vis. Sci. 2010;51(13):4928.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To measure retinal vascular leakage in mice eyes with MRI imaging

Methods: : Retinal vascular leakage was induced in mice eyes by generating choroidal Neovascularization (CNV) by laser-injury. Briefly, a 532nM argon laser was used to rupture Bruch’s membrane. Each mouse had 10 shots applied to one eye; the fellow non-lasered eye served as a control.MRI was conducted in a 4.7T Bruker PharmaScan (Bruker BioSpin, Ettlingen, Germany) using a T1 weighted spin-echo sequence. Images were acquired continuously for 30min during the administration of 1.0uL/g Gd-DTPA as contrast agent, at one image per 6 minutes with a resolution of 0.133x0.133x0.7 mm3. To quantify vascular leakage, a small region of interest is drawn in the vitreous. The signal intensity averaged from 6 to 24 min post-injection was calculated as a percentage of the pre-contrast intensity to determine the percent enhancement.Vascular leakage was compared between eyes on Day 5, 7, 19 & 26. In a second study, mice were lasered and were dosed with vehicle or a VEGF inhibitor. Vascular leakage was compared between treatment groups, and between the two eyes.

Results: : With the laser-induced lesion, prominent enhancement could be observed in the eye post injection of the contrast agent (observed on day 5 through 26). The enhancement can be tracked noninvasively and longitudinally. Moreover, treatment with a VEGF inhibitor is able to significantly reduce the enhancement.

Conclusions: : Using a laser-injury-induced mouse model of CNV, the present study shows that the resultant vascular leakage can be visualized and quantified by dynamic-contrast-enhanced MRI. Moreover, the technique can be used to assess treatment effect in this model, as demonstrated with administration of a VEGF inhibitor.

Keywords: choroid: neovascularization • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.